Correction of CNS defects in the MPSII mouse model via systemic enzyme replacement therapy

Mucopolysaccharidosis type II (MPSII), or Hunter syndrome, is a devastating disorder associated with a shortened life expectancy. Patients affected by MPSII have a variety of symptoms that affect all organs of the body and may include progressive cognitive impairment. MPSII is due to inactivity of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Polito, Vinicia Assunta, Abbondante, Serena, Polishchuk, Roman S., Nusco, Edoardo, Salvia, Rosaria, Cosma, Maria Pia
Formato: Texto
Lenguaje:English
Publicado: Oxford University Press 2010
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989894/
https://www.ncbi.nlm.nih.gov/pubmed/20876612
http://dx.doi.org/10.1093/hmg/ddq420

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2989894/
https://www.ncbi.nlm.nih.gov/pubmed/20876612
http://dx.doi.org/10.1093/hmg/ddq420

Ejemplares similares